Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about MAX: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
MAX is a gene implicated in neurodegeneration research. Key relationships include: associated with, regulates, inhibits. Associated with ALS, Aging, Als. Connected to 154 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | MAX |
| Full Name | MAX Protein |
| Chromosome | 14q23.3 |
| Protein Family | bHLH-LZ Transcription Factor Family |
| Protein Type | Transcription Factor |
| Function | MYC-MAX heterodimers activate target genes |
| Subcellular Localization | Nuclear |
| Molecular Weight | 18 kDa |
| Amino Acids | 160 aa |
| Pathways | Tgf-Β |
| UniProt ID | P61275 |
| GeneCards | MAX |
| Human Protein Atlas | MAX |
| Associated Diseases | Aging, Als, Autoimmune, Cancer, Ms |
| Interactions | AND, App, AQP4, AQUAPORIN-4, ASTROCYTE, CANCER |
| KG Connections | 215 knowledge graph edges |
| Databases | GeneCardsNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
MAX["MAX
Transcription Factor"]
CGAS["cGAS
DNA Sensor"]
STING["STING
Innate Immunity"]
PARP1["PARP1
DNA Repair"]
Neurodegeneration["Neurodegeneration
Progressive Loss"]
ALS["Amyotrophic Lateral
Sclerosis (ALS)"]
MS["Multiple Sclerosis
(MS)"]
Parkinsons["Parkinson's
Disease"]
Aging["Cellular
Aging"]
Autoimmune["Autoimmune
Response"]
Cancer["Cancer
Development"]
Tumor["Tumor
Formation"]
Inflammation["Chronic
Inflammation"]
DNA_Damage["DNA Damage
Response"]
Cell_Death["Neuronal
Cell Death"]
Therapeutic["Therapeutic
Target"]
MAX -->|"inhibits"| CGAS
MAX -->|"inhibits"| STING
MAX -->|"inhibits"| PARP1
CGAS -->|"activates"| STING
STING -->|"promotes"| Inflammation
PARP1 -->|"responds to"| DNA_Damage
MAX -->|"regulates"| Aging
MAX -->|"associated with"| Neurodegeneration
MAX -->|"activates"| ALS
MAX -->|"activates"| MS
MAX -->|"associated with"| Parkinsons
Inflammation -->|"contributes to"| Neurodegeneration
DNA_Damage -->|"leads to"| Cell_Death
Aging -->|"promotes"| Neurodegeneration
MAX -->|"activates"| Autoimmune
Autoimmune -->|"triggers"| MS
MAX -->|"therapeutic target"| Therapeutic
style MAX fill:#006494
style PARP1 fill:#4a1a6b
style CGAS fill:#4a1a6b
style STING fill:#4a1a6b
style Therapeutic fill:#1b5e20
style Neurodegeneration fill:#5d4400
style ALS fill:#ef5350
style MS fill:#ef5350
style Parkinsons fill:#ef5350
style Inflammation fill:#ef5350
style Cell_Death fill:#ef5350
style Autoimmune fill:#ef5350
style Cancer fill:#ef5350
style Aging fill:#5d4400| Target | Relation | Type | Str |
|---|---|---|---|
| Tumor | inhibits | disease | 0.85 |
| Cancer | inhibits | disease | 0.85 |
| Als | associated_with | disease | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| Neurodegeneration | therapeutic_target | disease | 0.75 |
| Aging | therapeutic_target | disease | 0.75 |
| Als | inhibits | disease | 0.75 |
| MYC | inhibits | gene | 0.70 |
| MYC | interacts_with | gene | 0.70 |
| Multiple Sclerosis | associated_with | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Myelodysplastic Syndrome | inhibits | disease | 0.65 |
| Parkinson | associated_with | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Depression | activates | disease | 0.65 |
| Cancer | associated_with | disease | 0.65 |
| Depression | transports | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Autoimmune | activates | disease | 0.65 |
| Encephalitis | activates | disease | 0.65 |
| Amyotrophic Lateral Sclerosis | therapeutic_target | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| Lymphoma | therapeutic_target | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Leukemia | inhibits | disease | 0.65 |
| Neuroblastoma | therapeutic_target | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Aging | regulates | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Multiple Sclerosis | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Autoimmune | associated_with | disease | 0.65 |
| Blood-Brain Barrier | therapeutic_target | pathway | 0.60 |
| Immune Response | inhibits | pathway | 0.60 |
| Innate Immunity | inhibits | pathway | 0.60 |
| Autophagy | associated_with | pathway | 0.60 |
| Oxidative Phosphorylation | expressed_in | pathway | 0.60 |
| AUTOPHAGY | associated_with | gene | 0.60 |
| MITOPHAGY | associated_with | gene | 0.60 |
| Oxidative Phosphorylation | associated_with | pathway | 0.60 |
| Endocytosis | interacts_with | pathway | 0.60 |
| NFL | therapeutic_target | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| CANCER | inhibits | gene | 0.80 |
| CANCER | therapeutic_target | gene | 0.60 |
| GENES | therapeutic_target | gene | 0.60 |
| GENES | interacts_with | gene | 0.60 |
| NEURODEGENERATION | therapeutic_target | gene | 0.60 |
| ALS | associated_with | gene | 0.60 |
| AND | associated_with | gene | 0.60 |
| MAO | inhibits | gene | 0.60 |
| AND | inhibits | gene | 0.60 |
| AND | regulates | gene | 0.60 |
| AND | expressed_in | gene | 0.60 |
| MITOPHAGY | associated_with | gene | 0.60 |
| AUTOPHAGY | associated_with | gene | 0.60 |
| RNA | associated_with | gene | 0.60 |
| DEPRESSION | activates | gene | 0.60 |
| GENES | associated_with | gene | 0.60 |
| ASTROCYTE | transports | gene | 0.60 |
| DEPRESSION | transports | gene | 0.60 |
| DRP1 | regulates | gene | 0.60 |
| TOMM20 | regulates | gene | 0.60 |
| AQP4 | activates | gene | 0.60 |
| APP | regulates | gene | 0.60 |
| ST6GAL1 | regulates | gene | 0.60 |
| PLA2G6 | therapeutic_target | gene | 0.60 |
| PANK2 | therapeutic_target | gene | 0.60 |
| STING | inhibits | gene | 0.60 |
| CGAS | inhibits | gene | 0.60 |
| MFF | regulates | gene | 0.60 |
| EMD | activates | gene | 0.60 |
| BACE1 | regulates | gene | 0.60 |
| OVERVIEW | expressed_in | gene | 0.60 |
| CGAS | activates | gene | 0.60 |
| IRF3 | activates | gene | 0.60 |
| AQP4 | associated_with | gene | 0.60 |
| EMD | associated_with | gene | 0.60 |
| APP | associated_with | gene | 0.60 |
| BACE1 | associated_with | gene | 0.60 |
| EGFR | associated_with | gene | 0.60 |
| FUT8 | associated_with | gene | 0.60 |
| PARP1 | inhibits | gene | 0.60 |
| IRF3 | inhibits | gene | 0.60 |
| MID51 | regulates | gene | 0.60 |
| MID49 | regulates | gene | 0.60 |
| MIRO1 | regulates | gene | 0.60 |
| FUT8 | regulates | gene | 0.60 |
| EGFR | regulates | gene | 0.60 |
| GAIN | therapeutic_target | gene | 0.60 |
| FUS | therapeutic_target | gene | 0.60 |
| AGING | regulates | gene | 0.60 |
| DNA | expressed_in | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Plasma p-tau217-Triggered Exosome Dosing Maximizes lncRNA-00 | 0.938 | molecular neurobiology | View |
| Cerebrospinal NFL-Triggered Liposome Dosing Maximizes lncRNA | 0.536 | molecular neurobiology | View |
| CSF Neurofilament Light-Triggered Astrocyte-Derived Exosome | 0.460 | molecular neurobiology | View |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning MAX in their description or question text
No additional research found